Terms: = Kidney tumors AND FES, FPS, 2242, ENSG00000182511, P07332 AND Treatment
4 results:
1. [Evaluation of the Short-Term Efficacy and Safety of Orelabrutinib Combined with High-Dose Methotrexate in the First-line treatment of Elderly Patients with High Risk Primary Central Nervous System Lymphoma].
Xie Y; Qu S; Liao LS; Zheng ZH; Lin Y; Chen WM; Chen BY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Dec; 31(6):1714-1719. PubMed ID: 38071050
[TBL] [Abstract] [Full Text] [Related]
2. An autopsy case of non-traumatic fat embolism syndrome.
Sakashita M; Sakashita S; Sakata A; Uesugi N; Ishige K; Hyodo I; Noguchi M
Pathol Int; 2017 Sep; 67(9):477-482. PubMed ID: 28667706
[TBL] [Abstract] [Full Text] [Related]
3. Systematic review and meta-analysis of target terapies for the treatment of metastatic renal cancer.
Durán M; Matheus W; Ferreira U; Clark O
Int Braz J Urol; 2013; 39(6):768-78. PubMed ID: 24456785
[TBL] [Abstract] [Full Text] [Related]
4. Downregulation of the c-fes protein-tyrosine kinase inhibits the proliferation of human renal carcinoma cells.
Kanda S; Miyata Y; Kanetake H; Smithgall TE
Int J Oncol; 2009 Jan; 34(1):89-96. PubMed ID: 19082481
[TBL] [Abstract] [Full Text] [Related]
